Skip to main content

Table 3 Regression models testing the association between occurrence of relapses during V1 and V2 (Poisson model) as well as EDSS change between V1 and V2 (linear model) with naïve vs switcher status and other covariates

From: Use of glatiramer acetate between 2010–2015: effectiveness, safety and reasons to start GA as first or second line treatment in Swiss multiple sclerosis patients

Predicted

Predictors

Regression coefficient

p

Relapses V1-V2

Naïve vs Switcher

−0.587

0.164

Gender (F)

−0.500

0.225

Age

−0.051

0.016

Disease duration

−0.020

0.566

ARR last 24 M

0.077

0.855

EDSS V1

0.179

0.279

EDSS V1-V2 change

Naïve vs Switcher

−0.436

0.008

Gender (F)

−0.081

0.641

Age

0.007

0.308

Disease duration

0.001

0.927

ARR last 24 months

−0.297

0.094

EDSS V1

−0.263

6.18E-05

  1. ARR Annualized relapse rate, EDSS Expanded disability status scale, V Visit